NN:EURONEXT AMSTERDAM
NN Group N.V.
Data as of 2026-03-11 - not real-time
$16.33
Latest Price
8/10Risk
Risk Level: High
Executive Summary
NextNav Inc. (NN) is trading at $16.33, just above the calculated support of $15.39 and slightly below the 20‑day SMA of $16.52, while remaining above the 50‑day SMA of $15.82, indicating a fragile bullish bias. The RSI sits at 51, suggesting neutral momentum, but the MACD histogram is negative and the signal line is bearish, warning of potential short‑term weakness. Volume is on an increasing trend, yet the 30‑day volatility is extremely high at 82.6% and beta is 1.12, pointing to pronounced price swings. Technical indicators therefore paint a mixed picture: bullish trend direction with notable downside risks.
On the fundamentals side, NN’s revenue has slumped 44.8% to $5.5 million, with gross margins of –64.6% and operating margins of –19.9%, reflecting an unprofitable core business. Cash balances of $167.6 million are outweighed by $245.8 million of debt, and the book value per share is negative (‑$0.164). The price‑to‑sales ratio is sky‑high at 397, and both PE and PB are negative, underscoring severe valuation concerns. There is no dividend, and the forward EPS remains negative. Despite these challenges, analysts’ median target price of $20 implies a modest upside of roughly 22%, and the Fear & Greed Index shows “Extreme Greed,” hinting at market optimism that may be disconnected from fundamentals. Overall, the stock balances a technically bullish setup against a fundamentally distressed backdrop.
On the fundamentals side, NN’s revenue has slumped 44.8% to $5.5 million, with gross margins of –64.6% and operating margins of –19.9%, reflecting an unprofitable core business. Cash balances of $167.6 million are outweighed by $245.8 million of debt, and the book value per share is negative (‑$0.164). The price‑to‑sales ratio is sky‑high at 397, and both PE and PB are negative, underscoring severe valuation concerns. There is no dividend, and the forward EPS remains negative. Despite these challenges, analysts’ median target price of $20 implies a modest upside of roughly 22%, and the Fear & Greed Index shows “Extreme Greed,” hinting at market optimism that may be disconnected from fundamentals. Overall, the stock balances a technically bullish setup against a fundamentally distressed backdrop.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price hovering just above support with bearish MACD signal
- High short‑term volatility (82.6% 30‑day)
- Increasing volume but limited upside near resistance at $17.55
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Technical bullish trend vs fundamentally weak earnings
- Target price of $20 suggests modest upside
- Cash runway sufficient but debt load remains high
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Strategic niche in PNT services for public safety and telecom
- Potential contract wins could improve cash flow
- Current market price offers ~22% upside to analyst target
Key Metrics & Analysis
Financial Health
Revenue Growth-44.80%
P/E Ratio-28.9
ROE-706.79%
ROA-19.17%
P/B Ratio-99.6
Op. Cash Flow$-46616000
Free Cash Flow$-15599750
Industry P/E36.8
Technical Analysis
TrendBullish
RSI51.0
Support$15.39
Resistance$17.55
MA 20$16.52
MA 50$15.82
MA 200$14.94
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Target Price$20.00
Upside/Downside22.47%
GradeOvervalued
TypeBlend
Risk Assessment
Beta1.12
Volatility82.63%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
More Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.